We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1726
Penske Automotive Group
PAG
$13.9B
| $1.1M | ﹤0.01% |
7,361
-1,166
| -14% | -$185K |
2025 Q4
1 quarter
|
|
1727
Interface
TILE
$2.08B
| $1.1M | ﹤0.01% |
44,124
+33,489
| +315% | +$1M |
2025 Q4
1 quarter
|
|
1728
John B. Sanfilippo & Son
JBSS
$773M
| $1.1M | ﹤0.01% |
13,837
+9,518
| +220% | +$733K |
2025 Q4
1 quarter
|
|
1729
Sundial Growers
SNDL
$298M
| $1.09M | ﹤0.01% |
828,494
+298,166
| +56% | +$456K |
2024 Q1
8 quarters
|
|
1730
NVE Corp
NVEC
$502M
| $1.09M | ﹤0.01% |
+16,658
| New | +$1.12M |
2026 Q1
0 quarters
|
|
1731
Verisk Analytics
VRSK
$24.4B
| $1.09M | ﹤0.01% |
5,745
-12,806
| -69% | -$2.6M |
2023 Q4
9 quarters
|
|
1732
Runway Growth Finance
RWAY
$264M
| $1.07M | ﹤0.01% |
155,261
+80,686
| +108% | +$670K |
2025 Q2
3 quarters
|
|
1733
CorVel
CRVL
$4.06B
| $1.06M | ﹤0.01% |
19,407
+1,621
| +9% | +$93.3K |
2023 Q4
9 quarters
|
|
1734
BlackLine
BL
$1.77B
| $1.06M | ﹤0.01% |
28,534
+175
| +0.6% | +$7.54K |
2025 Q2
3 quarters
|
|
1735
Perdoceo Education
PRDO
$2.12B
| $1.05M | ﹤0.01% |
28,338
-10,026
| -26% | -$331K |
2025 Q1
4 quarters
|
|
1736
TKO Group
TKO
$12.9B
| $1.05M | ﹤0.01% |
5,204
-6,314
| -55% | -$1.29M |
2023 Q3
10 quarters
|
|
1737
Cohen & Steers
CNS
$3.55B
| $1.05M | ﹤0.01% |
+16,769
| New | +$1.09M |
2026 Q1
0 quarters
|
|
1738
Lifestance Health
LFST
$4.7B
| $1.05M | ﹤0.01% |
+164,507
| New | +$1.14M |
2026 Q1
0 quarters
|
|
1739
SI-BONE Inc
SIBN
$892M
| $1.05M | ﹤0.01% |
82,811
+33,895
| +69% | +$530K |
2025 Q4
1 quarter
|
|
1740
Weatherford International
WFRD
$5.36B
| $1.04M | ﹤0.01% |
11,033
-87,576
| -89% | -$8.24M |
2025 Q2
3 quarters
|
|
1741
Farmland Partners
FPI
$460M
| $1.04M | ﹤0.01% |
92,879
-38,927
| -30% | -$446K |
2025 Q3
2 quarters
|
|
1742
Advance Auto Parts
AAP
$2.65B
| $1.04M | ﹤0.01% |
19,739
-36,607
| -65% | -$1.83M |
2025 Q4
1 quarter
|
|
1743
Compañía de Minas Buenaventura
BVN
$7.91B
| $1.04M | ﹤0.01% |
+28,800
| New | +$1.04M |
2026 Q1
0 quarters
|
|
1744
Affirm
AFRM
$25.6B
| $1.04M | ﹤0.01% |
22,594
+13,670
| +153% | +$790K |
2023 Q4
9 quarters
|
|
1745
InfuSystem Holdings
INFU
$277M
| $1.03M | ﹤0.01% |
112,106
+58,910
| +111% | +$514K |
2025 Q3
2 quarters
|
|
1746
Electromed
ELMD
$232M
| $1.03M | ﹤0.01% |
43,899
+17,270
| +65% | +$450K |
2025 Q1
4 quarters
|
|
1747
Amrize Ltd
AMRZ
$20.4B
| $1.02M | ﹤0.01% |
18,281
-6,195
| -25% | -$355K |
2025 Q3
2 quarters
|
|
1748
Appian
APPN
$3.14B
| $1.02M | ﹤0.01% |
42,440
-6,246
| -13% | -$170K |
2024 Q4
5 quarters
|
|
1749
Praxis Precision Medicines
PRAX
$6.93B
| $1.02M | ﹤0.01% |
3,173
-17,997
| -85% | -$5.57M |
2025 Q4
1 quarter
|
|
1750
Dr. Reddy's Laboratories
RDY
$10.7B
| $1.02M | ﹤0.01% |
73,752
-151,847
| -67% | -$2.11M |
2025 Q4
1 quarter
|
|
Similar funds
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.